» Articles » PMID: 29036388

Risk Factors for Suicidality in Patients With Schizophrenia: A Systematic Review, Meta-analysis, and Meta-regression of 96 Studies

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2017 Oct 17
PMID 29036388
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The lifetime risk of suicide and suicide attempt in patients with schizophrenia are 5% and 25%-50%, respectively. The current meta-analysis aims to determine risk factors associated with suicidality in subjects with schizophrenia. We searched Pubmed, Web of Science, EMBASE, and the reference lists of included studies. Inclusion criteria were met if an article reported a dichotomous sample of patients with schizophrenia with suicidal ideation, attempted suicide, or suicide compared to patients without. We also performed a cohort study meta-analysis as a supplemental analysis. A total of 96 studies with 80488 participants were included in our analysis. Depressive symptoms (P < .0001), Positive and Negative Symptom Scale (PANSS) general score (P < .0001) and number of psychiatric hospitalizations (P < .0001) were higher in patients with suicide ideation. History of alcohol use (P = .0001), family history of psychiatric illness (P < .0001), physical comorbidity (P < .0001), history of depression (P < .0001), family history of suicide (P < .0001), history of drug use (P = .0024), history of tobacco use (P = .0034), being white (P = .0022), and depressive symptoms (P < .0001) were the most consistent variables associated with suicide attempts. The first two were also significant in the cohort meta-analysis. Being male (P = .0005), history of attempted suicide (P < .0001), younger age (P = .0266), higher intelligence quotient (P < .0001), poor adherence to treatment (P < .0001), and hopelessness (P < .0001) were the most consistently associated with suicide. The first three were also significant in the cohort meta-analysis. Our findings may help with future development of preventive strategies to combat suicide. Future studies may combine the above-mentioned variables by using multivariate predictive analysis techniques to objectively stratify suicidality in schizophrenia.

Citing Articles

Sleep deficiencies and suicidal ideation across the psychosis continuum.

Wastler H, Blouin A, Kilicoglu M, Bozzay M Front Psychiatry. 2025; 16:1540497.

PMID: 39975948 PMC: 11835922. DOI: 10.3389/fpsyt.2025.1540497.


Reasons for Thinking About Suicide Among Individuals With First-Episode Psychosis: An Ecological Momentary Assessment Study.

Wastler H, Manges M, Thompson E, Bornheimer L Early Interv Psychiatry. 2025; 19(3):e13640.

PMID: 39754486 PMC: 11904262. DOI: 10.1111/eip.13640.


Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study.

Stromme M, Thue Augustsson M, Bartz-Johannessen C, Stautland A, Mykletun A, Kroken R Psychol Med. 2024; :1-9.

PMID: 39651581 PMC: 11780172. DOI: 10.1017/S0033291724002873.


Prevalence of treatment-resistant depression and associated factors among major depressive disorder follow-up patients at Saint Amanuel Mental Specialised Hospital in Ethiopia: a cross-sectional study.

Siyoum M, Kibrom E, Fanta T, Matheyose E, Adem K, Bekele D BMJ Open. 2024; 14(11):e087006.

PMID: 39609013 PMC: 11603831. DOI: 10.1136/bmjopen-2024-087006.


Gender-specific correlates for suicide mortality in people with schizophrenia: a 9-year population-based study.

Pan Z, Zhou L, Chen Y, Su J, Duan X, Zhong S BMC Psychiatry. 2024; 24(1):692.

PMID: 39415139 PMC: 11481785. DOI: 10.1186/s12888-024-06089-0.


References
1.
Kochanek K, Xu J, Murphy S, Minino A, Kung H . Deaths: final data for 2009. Natl Vital Stat Rep. 2014; 60(3):1-116. View

2.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

3.
Popovic D, Benabarre A, Crespo J, Goikolea J, Gonzalez-Pinto A, Gutierrez-Rojas L . Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand. 2014; 130(6):418-26. DOI: 10.1111/acps.12332. View

4.
Siris S . Suicide and schizophrenia. J Psychopharmacol. 2001; 15(2):127-35. DOI: 10.1177/026988110101500209. View

5.
Viechtbauer W, Lopez-Lopez J, Sanchez-Meca J, Marin-Martinez F . A comparison of procedures to test for moderators in mixed-effects meta-regression models. Psychol Methods. 2014; 20(3):360-74. DOI: 10.1037/met0000023. View